Celldex Therapeutics Inc
F:TCE2
Celldex Therapeutics Inc
F:TCE2
Price:
34.26
EUR
-1.75%
Market Closed
Market Cap:
€2.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Celldex Therapeutics Inc
F:TCE2
|
US |
|
K
|
Kawasaki Heavy Industries Ltd
XMUN:KHE
|
JP |
|
I
|
IAMGOLD Corp
F:IAL
|
CA |
|
S
|
Siemens AG
XBER:SIE
|
DE |
|
C
|
Celldex Therapeutics Inc
SWB:TCE2
|
US |
|
I
|
ITV PLC
XMUN:IJ7
|
UK |
|
F
|
Frontline Ltd
F:FRLN
|
BM |
|
Lument Finance Trust Inc
F:70X
|
US |
|
Delek US Holdings Inc
NYSE:DK
|
US |
|
S
|
Societe Generale SA
BMV:GLEN
|
FR |
|
F
|
Fuji Media Holdings Inc
F:FTN
|
JP |
|
S
|
State Street Corp
BMV:STT
|
US |
|
F
|
Fresnillo PLC
F:FNL
|
MX |
|
Perella Weinberg Partners
NASDAQ:PWP
|
US |
|
Atlas Arteria Group
ASX:ALX
|
AU |
Wall St Price Targets
TCE2 Price Targets Summary
Celldex Therapeutics Inc
Celldex Therapeutics Inc
Wall Street analysts forecast TCE2 stock price to drop over the next 12 months.
According to Wall Street analysts, the average 1-year price target for TCE2 is 32.25 EUR with a low forecast of 21.16 EUR and a high forecast of 57.88 EUR.
Lowest Forecast
Price Target
21.16
EUR
38% Downside
Average Forecast
Price Target
32.25
EUR
6% Downside
Highest Forecast
Price Target
57.88
EUR
69% Upside
Celldex Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TCE2's stock price target?
Price Target
32.25
EUR
32.25
EUR
According to Wall Street analysts, the average 1-year price target for TCE2 is 32.25 EUR with a low forecast of 21.16 EUR and a high forecast of 57.88 EUR.
What is the Revenue forecast for Celldex Therapeutics Inc?
Projected CAGR
147%
147%
Over the last 13 years, the compound annual growth rate for Revenue has been -14%. The projected CAGR for the next 8 years is 147%.
